Skip to main content
Journal of Ophthalmic Inflammation and Infection
Fig. 2 | Journal of Ophthalmic Inflammation and Infection

Fig. 2

From: Serum IgE reduction and paradoxical eosinophilia associated with allergic conjunctivitis after dupilumab therapy

Fig. 2

Decreased levels of IgE and paradoxical transient eosinophilia in peripheral blood after dupilumab therapy. IgE level decreased markedly from 23,100 IU/mL at 3 weeks before to 8520 IU/mL at 10 weeks after dupilumab administration (a). The number of eosinophils paradoxically increased from 365 cells/μL at 3 weeks before to 1400 cells/μL at 10 weeks after dupilumab administration (b)

Back to article page